GSK, CureVac's next-gen COVID-19 vaccine shows promise in monkey trial

[cafead]

via GlaxoSmithKline (GSK.L) and CureVac (5CV.DE) said a study on macaque monkeys showed their jointly-developed mRNA COVID-19 vaccine candidate to be "strongly improved" in protecting against the virus compared with CureVac's first attempt.

article source